Literature DB >> 18397823

MUC4 interacts with ErbB2 in human gallbladder carcinoma: potential pathobiological implications.

Naoki Miyahara1, Junichi Shoda, Kazunori Ishige, Toru Kawamoto, Tetsuya Ueda, Ryuuichi Taki, Nobuhiro Ohkohchi, Ichinosuke Hyodo, Melanie B Thomas, Savitri Krishnamurthy, Kermit L Carraway, Tatsuro Irimura.   

Abstract

Muc4 interacts with erbB2 and potentiates tumourigenesis and/or tumour growth. The expression of MUC4, the interaction of MUC4 with erbB2 and the status of erbB2 signalling in human gallbladder carcinomas were determined in order to gain a better understanding of the pathobiology. The expression levels of MUC4 protein and mRNA were increased in specimens of gallbladder carcinoma. Immunoprecipitation experiments showed an interaction between MUC4 and erbB2. This interaction was associated with the hyperphosphorylation of erbB2, MAPK and Akt and with the overexpression of cyclooxygenase-2. MUC4 was detected on the apical surface of cancerous epithelia and partially co-localised there with erbB2. Transfection experiments showed that MUC4 amplifies cell proliferation in the presence of heregulin through potentiating phosphorylation of erbB2 and its downstream signalling pathways. These findings suggest that MUC4 is up-regulated and interacts with erbB2 in human gallbladder carcinoma, and thereby support the potential implication of MUC4 in erbB2 activation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18397823     DOI: 10.1016/j.ejca.2008.03.007

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  20 in total

Review 1.  Mucins and toll-like receptors: kith and kin in infection and cancer.

Authors:  Shikha Tarang; Sushil Kumar; Surinder K Batra
Journal:  Cancer Lett       Date:  2012-02-03       Impact factor: 8.679

2.  Upregulation of mucin4 in ER-positive/HER2-overexpressing breast cancer xenografts with acquired resistance to endocrine and HER2-targeted therapies.

Authors:  Albert C Chen; Ilenia Migliaccio; Mothaffar Rimawi; Sara Lopez-Tarruella; Chad J Creighton; Suleiman Massarweh; Catherine Huang; Yen-Chao Wang; Surinder K Batra; M Carolina Gutierrez; C Kent Osborne; Rachel Schiff
Journal:  Breast Cancer Res Treat       Date:  2012-05-29       Impact factor: 4.872

3.  Early response to ErbB2 over-expression in polarized Caco-2 cells involves partial segregation from ErbB3 by relocalization to the apical surface and initiation of survival signaling.

Authors:  Amber B Pfister; Robert C Wood; Pedro J I Salas; Delma L Zea; Victoria P Ramsauer
Journal:  J Cell Biochem       Date:  2010-10-15       Impact factor: 4.429

4.  Prognostic value of mucin 4 expression in colorectal adenocarcinomas.

Authors:  Chandrakumar Shanmugam; Nirag C Jhala; Venkat R Katkoori; Wen Wan; Sreelatha Meleth; William E Grizzle; Upender Manne
Journal:  Cancer       Date:  2010-08-01       Impact factor: 6.860

5.  Factor VIII light chain contains a binding site for factor X that contributes to the catalytic efficiency of factor Xase.

Authors:  Masahiro Takeyama; Hironao Wakabayashi; Philip J Fay
Journal:  Biochemistry       Date:  2012-01-17       Impact factor: 3.162

6.  MUC4 down-regulation reverses chemoresistance of pancreatic cancer stem/progenitor cells and their progenies.

Authors:  Murielle Mimeault; Sonny L Johansson; Shantibhusan Senapati; Navneet Momi; Subhankar Chakraborty; Surinder K Batra
Journal:  Cancer Lett       Date:  2010-03-19       Impact factor: 8.679

7.  The membrane mucin Muc4 inhibits apoptosis induced by multiple insults via ErbB2-dependent and ErbB2-independent mechanisms.

Authors:  Heather C Workman; Colleen Sweeney; Kermit L Carraway
Journal:  Cancer Res       Date:  2009-03-17       Impact factor: 12.701

Review 8.  Mucins in cancer: function, prognosis and therapy.

Authors:  Donald W Kufe
Journal:  Nat Rev Cancer       Date:  2009-12       Impact factor: 60.716

9.  Mice deficient in Muc4 are resistant to experimental colitis and colitis-associated colorectal cancer.

Authors:  S Das; S Rachagani; Y Sheinin; L M Smith; C B Gurumurthy; H K Roy; S K Batra
Journal:  Oncogene       Date:  2015-09-14       Impact factor: 9.867

10.  The membrane mucin MUC4 is elevated in breast tumor lymph node metastases relative to matched primary tumors and confers aggressive properties to breast cancer cells.

Authors:  Heather C Workman; Jamie K Miller; Ellen Q Ingalla; Rouminder P Kaur; Diane I Yamamoto; Laurel A Beckett; Lawrence Jt Young; Robert D Cardiff; Alexander D Borowsky; Kermit L Carraway; Colleen Sweeney; Kermit L Carraway
Journal:  Breast Cancer Res       Date:  2009       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.